Concepedia

Publication | Closed Access

Phase I study of an oral formulation of irinotecan administered daily for 14�days every 3�weeks in patients with advanced solid tumours

DOI

29

Citations

24

References

2004

Year

Nadja E. Schoemaker, I. E. L. M. Kuppens, W.W. ten Bokkel Huinink, P Lefebvre, Jos H. Beijnen, Sylvie Assadourian, Ger‐Jan Sanderink, Jan H.M. Schellens
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1